US9309546B2 - Genetically modified cell and process for use of said cell - Google Patents
Genetically modified cell and process for use of said cell Download PDFInfo
- Publication number
- US9309546B2 US9309546B2 US14/003,386 US201214003386A US9309546B2 US 9309546 B2 US9309546 B2 US 9309546B2 US 201214003386 A US201214003386 A US 201214003386A US 9309546 B2 US9309546 B2 US 9309546B2
- Authority
- US
- United States
- Prior art keywords
- hmf
- cell
- acid
- polypeptide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related, expires
Links
- 238000000034 method Methods 0.000 title claims abstract description 31
- 230000008569 process Effects 0.000 title claims abstract description 19
- PCSKKIUURRTAEM-UHFFFAOYSA-N 5-hydroxymethyl-2-furoic acid Chemical compound OCC1=CC=C(C(O)=O)O1 PCSKKIUURRTAEM-UHFFFAOYSA-N 0.000 claims abstract description 127
- 239000013598 vector Substances 0.000 claims abstract description 46
- 239000002243 precursor Substances 0.000 claims abstract description 20
- 230000036983 biotransformation Effects 0.000 claims abstract description 15
- CHTHALBTIRVDBM-UHFFFAOYSA-N furan-2,5-dicarboxylic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)O1 CHTHALBTIRVDBM-UHFFFAOYSA-N 0.000 claims description 135
- 210000004027 cell Anatomy 0.000 claims description 116
- 229920001184 polypeptide Polymers 0.000 claims description 84
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 84
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 84
- 102000040430 polynucleotide Human genes 0.000 claims description 83
- 108091033319 polynucleotide Proteins 0.000 claims description 83
- 239000002157 polynucleotide Substances 0.000 claims description 83
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 claims description 57
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 52
- 241000589776 Pseudomonas putida Species 0.000 claims description 30
- 230000000694 effects Effects 0.000 claims description 23
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 claims description 22
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 claims description 22
- 102000004316 Oxidoreductases Human genes 0.000 claims description 21
- 108090000854 Oxidoreductases Proteins 0.000 claims description 21
- 241001345111 Pseudomonas putida S12 Species 0.000 claims description 21
- 238000007254 oxidation reaction Methods 0.000 claims description 20
- SHNRXUWGUKDPMA-UHFFFAOYSA-N 5-formyl-2-furoic acid Chemical compound OC(=O)C1=CC=C(C=O)O1 SHNRXUWGUKDPMA-UHFFFAOYSA-N 0.000 claims description 17
- DSLRVRBSNLHVBH-UHFFFAOYSA-N 2,5-furandimethanol Chemical compound OCC1=CC=C(CO)O1 DSLRVRBSNLHVBH-UHFFFAOYSA-N 0.000 claims description 14
- 230000003647 oxidation Effects 0.000 claims description 13
- 241001430258 Methylobacterium radiotolerans Species 0.000 claims description 9
- PXJJKVNIMAZHCB-UHFFFAOYSA-N 2,5-diformylfuran Chemical compound O=CC1=CC=C(C=O)O1 PXJJKVNIMAZHCB-UHFFFAOYSA-N 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 8
- 230000002538 fungal effect Effects 0.000 claims description 8
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 7
- 241001528539 Cupriavidus necator Species 0.000 claims description 7
- 241000588724 Escherichia coli Species 0.000 claims description 7
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 6
- 241000589323 Methylobacterium Species 0.000 claims description 6
- 241000235648 Pichia Species 0.000 claims description 6
- 241000589516 Pseudomonas Species 0.000 claims description 6
- 230000001590 oxidative effect Effects 0.000 claims description 6
- 235000000346 sugar Nutrition 0.000 claims description 6
- 241000589173 Bradyrhizobium Species 0.000 claims description 5
- 241000589174 Bradyrhizobium japonicum Species 0.000 claims description 5
- 241001453380 Burkholderia Species 0.000 claims description 5
- 241001528480 Cupriavidus Species 0.000 claims description 5
- 241000197701 Methylobacterium nodulans Species 0.000 claims description 5
- 241000866630 Paraburkholderia graminis Species 0.000 claims description 5
- 241001343907 Paraburkholderia phymatum Species 0.000 claims description 5
- 241000037463 Paraburkholderia phytofirmans Species 0.000 claims description 5
- 241001509383 Paraburkholderia xenovorans Species 0.000 claims description 5
- 241000205101 Sulfolobus Species 0.000 claims description 5
- 241000205098 Sulfolobus acidocaldarius Species 0.000 claims description 5
- -1 hexose sugars Chemical class 0.000 claims description 5
- 241000588853 Acidiphilium Species 0.000 claims description 4
- 241000589158 Agrobacterium Species 0.000 claims description 4
- 241000228212 Aspergillus Species 0.000 claims description 4
- 241000123346 Chrysosporium Species 0.000 claims description 4
- 241001608865 Methylovorus Species 0.000 claims description 4
- 241000228143 Penicillium Species 0.000 claims description 4
- 241000232299 Ralstonia Species 0.000 claims description 4
- 241000589180 Rhizobium Species 0.000 claims description 4
- 241000589194 Rhizobium leguminosarum Species 0.000 claims description 4
- 241000589193 Rhizobium leguminosarum bv. trifolii Species 0.000 claims description 4
- 241000736131 Sphingomonas Species 0.000 claims description 4
- 241000187747 Streptomyces Species 0.000 claims description 4
- 241000167564 Sulfolobus islandicus Species 0.000 claims description 4
- 241000205091 Sulfolobus solfataricus Species 0.000 claims description 4
- 241000160715 Sulfolobus tokodaii Species 0.000 claims description 4
- 241000228341 Talaromyces Species 0.000 claims description 4
- 241000223259 Trichoderma Species 0.000 claims description 4
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 3
- 241000589220 Acetobacter Species 0.000 claims description 3
- 241000588849 Acidiphilium cryptum Species 0.000 claims description 3
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 claims description 3
- 241000222518 Agaricus Species 0.000 claims description 3
- 241000192542 Anabaena Species 0.000 claims description 3
- 241001513093 Aspergillus awamori Species 0.000 claims description 3
- 241000892910 Aspergillus foetidus Species 0.000 claims description 3
- 241001225321 Aspergillus fumigatus Species 0.000 claims description 3
- 241000228245 Aspergillus niger Species 0.000 claims description 3
- 240000006439 Aspergillus oryzae Species 0.000 claims description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 3
- 241000131386 Aspergillus sojae Species 0.000 claims description 3
- 241000223651 Aureobasidium Species 0.000 claims description 3
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 3
- 241000006382 Bacillus halodurans Species 0.000 claims description 3
- 241000194108 Bacillus licheniformis Species 0.000 claims description 3
- 241000194107 Bacillus megaterium Species 0.000 claims description 3
- 241000194103 Bacillus pumilus Species 0.000 claims description 3
- 244000063299 Bacillus subtilis Species 0.000 claims description 3
- 241000606125 Bacteroides Species 0.000 claims description 3
- 241000186146 Brevibacterium Species 0.000 claims description 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 3
- 241000863012 Caulobacter Species 0.000 claims description 3
- 241000010804 Caulobacter vibrioides Species 0.000 claims description 3
- 241001674013 Chrysosporium lucknowense Species 0.000 claims description 3
- 241000222511 Coprinus Species 0.000 claims description 3
- 241000186216 Corynebacterium Species 0.000 claims description 3
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 3
- 241001337994 Cryptococcus <scale insect> Species 0.000 claims description 3
- 241000983824 Dinoroseobacter Species 0.000 claims description 3
- 241001595867 Dinoroseobacter shibae Species 0.000 claims description 3
- 241000588914 Enterobacter Species 0.000 claims description 3
- 241000588722 Escherichia Species 0.000 claims description 3
- 241000589565 Flavobacterium Species 0.000 claims description 3
- 241000223218 Fusarium Species 0.000 claims description 3
- 241000589236 Gluconobacter Species 0.000 claims description 3
- 241000589232 Gluconobacter oxydans Species 0.000 claims description 3
- 241000223198 Humicola Species 0.000 claims description 3
- 241000588748 Klebsiella Species 0.000 claims description 3
- 241000235649 Kluyveromyces Species 0.000 claims description 3
- 241001138401 Kluyveromyces lactis Species 0.000 claims description 3
- 241000235058 Komagataella pastoris Species 0.000 claims description 3
- 241000186660 Lactobacillus Species 0.000 claims description 3
- 241000194036 Lactococcus Species 0.000 claims description 3
- 241001344133 Magnaporthe Species 0.000 claims description 3
- 241000604449 Megasphaera Species 0.000 claims description 3
- 241000589308 Methylobacterium extorquens Species 0.000 claims description 3
- 241000235395 Mucor Species 0.000 claims description 3
- 241000226677 Myceliophthora Species 0.000 claims description 3
- 241000233892 Neocallimastix Species 0.000 claims description 3
- 241000221960 Neurospora Species 0.000 claims description 3
- 241000320412 Ogataea angusta Species 0.000 claims description 3
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 claims description 3
- 241001057811 Paracoccus <mealybug> Species 0.000 claims description 3
- 241000589597 Paracoccus denitrificans Species 0.000 claims description 3
- 241000228150 Penicillium chrysogenum Species 0.000 claims description 3
- 241000222385 Phanerochaete Species 0.000 claims description 3
- 241000235379 Piromyces Species 0.000 claims description 3
- 241000222350 Pleurotus Species 0.000 claims description 3
- 241000589625 Ralstonia pickettii Species 0.000 claims description 3
- 241000959173 Rasamsonia emersonii Species 0.000 claims description 3
- 241000191025 Rhodobacter Species 0.000 claims description 3
- 241000191043 Rhodobacter sphaeroides Species 0.000 claims description 3
- 241000190932 Rhodopseudomonas Species 0.000 claims description 3
- 241000190950 Rhodopseudomonas palustris Species 0.000 claims description 3
- 241000235070 Saccharomyces Species 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 3
- 241000235060 Scheffersomyces stipitis Species 0.000 claims description 3
- 241000222480 Schizophyllum Species 0.000 claims description 3
- 241000235346 Schizosaccharomyces Species 0.000 claims description 3
- 241000605036 Selenomonas Species 0.000 claims description 3
- 241001135312 Sinorhizobium Species 0.000 claims description 3
- 241000589196 Sinorhizobium meliloti Species 0.000 claims description 3
- 241000191940 Staphylococcus Species 0.000 claims description 3
- 241000191965 Staphylococcus carnosus Species 0.000 claims description 3
- 241000194017 Streptococcus Species 0.000 claims description 3
- 241000187398 Streptomyces lividans Species 0.000 claims description 3
- 241000228178 Thermoascus Species 0.000 claims description 3
- 241001494489 Thielavia Species 0.000 claims description 3
- 241001149964 Tolypocladium Species 0.000 claims description 3
- 241000499912 Trichoderma reesei Species 0.000 claims description 3
- 241000235013 Yarrowia Species 0.000 claims description 3
- 241000235015 Yarrowia lipolytica Species 0.000 claims description 3
- 241000588901 Zymomonas Species 0.000 claims description 3
- 229940091771 aspergillus fumigatus Drugs 0.000 claims description 3
- 229940039696 lactobacillus Drugs 0.000 claims description 3
- 210000005253 yeast cell Anatomy 0.000 claims description 3
- 238000003916 acid precipitation Methods 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000018044 dehydration Effects 0.000 claims description 2
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims description 2
- 238000000638 solvent extraction Methods 0.000 claims description 2
- NOEGNKMFWQHSLB-IDEBNGHGSA-N 5-(hydroxymethyl)furan-2-carbaldehyde Chemical group O[13CH2][13C]1=[13CH][13CH]=[13C]([13CH]=O)O1 NOEGNKMFWQHSLB-IDEBNGHGSA-N 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 21
- 230000009466 transformation Effects 0.000 abstract description 4
- 230000002210 biocatalytic effect Effects 0.000 abstract description 3
- 238000012239 gene modification Methods 0.000 abstract description 3
- 230000005017 genetic modification Effects 0.000 abstract description 3
- 235000013617 genetically modified food Nutrition 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 description 53
- 241000960359 Cupriavidus basilensis Species 0.000 description 31
- 238000004519 manufacturing process Methods 0.000 description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- 235000001014 amino acid Nutrition 0.000 description 20
- 229940024606 amino acid Drugs 0.000 description 19
- 150000001413 amino acids Chemical class 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 239000002773 nucleotide Substances 0.000 description 18
- 125000003729 nucleotide group Chemical group 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 17
- 102000053602 DNA Human genes 0.000 description 17
- 238000009825 accumulation Methods 0.000 description 16
- 230000014509 gene expression Effects 0.000 description 16
- 235000018102 proteins Nutrition 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- 239000013612 plasmid Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 12
- 239000002609 medium Substances 0.000 description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000003155 DNA primer Substances 0.000 description 9
- HYBBIBNJHNGZAN-UHFFFAOYSA-N Furaldehyde Natural products O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 9
- 230000004186 co-expression Effects 0.000 description 9
- 244000005700 microbiome Species 0.000 description 9
- 108020001019 DNA Primers Proteins 0.000 description 8
- 241001378936 Methylobacterium radiotolerans JCM 2831 Species 0.000 description 8
- 239000013615 primer Substances 0.000 description 8
- 150000007523 nucleic acids Chemical group 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 241000274790 Bradyrhizobium diazoefficiens USDA 110 Species 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 230000010076 replication Effects 0.000 description 6
- 239000002028 Biomass Substances 0.000 description 5
- 108010078791 Carrier Proteins Proteins 0.000 description 5
- 241000308162 Sulfolobus acidocaldarius DSM 639 Species 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 229920002477 rna polymer Polymers 0.000 description 5
- 229960001860 salicylate Drugs 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- 241001135756 Alphaproteobacteria Species 0.000 description 4
- 241001135755 Betaproteobacteria Species 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 4
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 4
- 101150067366 adh gene Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000002551 biofuel Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 210000003527 eukaryotic cell Anatomy 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 241000894007 species Species 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
- 241000131971 Bradyrhizobiaceae Species 0.000 description 3
- 241001600148 Burkholderiales Species 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 229930182566 Gentamicin Natural products 0.000 description 3
- 241000253389 Methylobacteriaceae Species 0.000 description 3
- 241001633102 Rhizobiaceae Species 0.000 description 3
- 241000589157 Rhizobiales Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 229960002518 gentamicin Drugs 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VEPOHXYIFQMVHW-PVJVQHJQSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;(2s,3s)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.O1CCN(C)[C@@H](C)[C@@H]1C1=CC=CC=C1 VEPOHXYIFQMVHW-PVJVQHJQSA-N 0.000 description 2
- 241001156739 Actinobacteria <phylum> Species 0.000 description 2
- 241000203809 Actinomycetales Species 0.000 description 2
- 241000193833 Bacillales Species 0.000 description 2
- 241000253402 Burkholderiaceae Species 0.000 description 2
- 241001137853 Crenarchaeota Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001137858 Euryarchaeota Species 0.000 description 2
- 241000192128 Gammaproteobacteria Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 101000648505 Homo sapiens Tumor necrosis factor receptor superfamily member 12A Proteins 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 239000006137 Luria-Bertani broth Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241001655325 Micromonosporales Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- 241000192142 Proteobacteria Species 0.000 description 2
- 241000204102 Pseudonocardiaceae Species 0.000 description 2
- 241001655323 Pseudonocardiales Species 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 241001655322 Streptomycetales Species 0.000 description 2
- 241000205074 Sulfolobales Species 0.000 description 2
- 241000204668 Thermoplasmatales Species 0.000 description 2
- 241000205175 Thermoproteaceae Species 0.000 description 2
- 241001074901 Thermoprotei Species 0.000 description 2
- 102100028786 Tumor necrosis factor receptor superfamily member 12A Human genes 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000006652 catabolic pathway Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 235000004400 serine Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000002374 tyrosine Nutrition 0.000 description 2
- 239000013603 viral vector Substances 0.000 description 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- 0 *.*C.CF.F.FF.O=C(O)C1=CC=C(C(=O)O)O1.O=C(O)C1=CC=C(CO)O1.O=CC1=CC=C(C(=O)O)O1.O=CC1=CC=C(C=O)O1.O=CC1=CC=C(CO)O1.OCC1=CC=C(CO)O1.[2H]F.[2H]F Chemical compound *.*C.CF.F.FF.O=C(O)C1=CC=C(C(=O)O)O1.O=C(O)C1=CC=C(CO)O1.O=CC1=CC=C(C(=O)O)O1.O=CC1=CC=C(C=O)O1.O=CC1=CC=C(CO)O1.OCC1=CC=C(CO)O1.[2H]F.[2H]F 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 241000123663 Actinosynnema Species 0.000 description 1
- 241000123665 Actinosynnema mirum Species 0.000 description 1
- 241000190801 Afipia Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 102000014290 Aldehyde oxidase/xanthine dehydrogenases Human genes 0.000 description 1
- 108050003195 Aldehyde oxidase/xanthine dehydrogenases Proteins 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241001112741 Bacillaceae Species 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000371430 Burkholderia cenocepacia Species 0.000 description 1
- 241001291866 Caldivirga Species 0.000 description 1
- 241001291868 Caldivirga maquilingensis Species 0.000 description 1
- 241000555398 Candidatus Parvarchaeum Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000005870 Coenzyme A Ligases Human genes 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000011426 Enoyl-CoA hydratase Human genes 0.000 description 1
- 108010023922 Enoyl-CoA hydratase Proteins 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- 241000193419 Geobacillus kaustophilus Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241001148465 Janthinobacterium Species 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 241000134732 Metallosphaera Species 0.000 description 1
- 241000157876 Metallosphaera sedula Species 0.000 description 1
- 241001453272 Methylophilaceae Species 0.000 description 1
- 241000187708 Micromonospora Species 0.000 description 1
- 241001134635 Micromonosporaceae Species 0.000 description 1
- 241000233654 Oomycetes Species 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 241001277521 Oxalobacteraceae Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000316734 Rhizobium/Agrobacterium group Species 0.000 description 1
- 241000187560 Saccharopolyspora Species 0.000 description 1
- 241000187559 Saccharopolyspora erythraea Species 0.000 description 1
- 241000204098 Saccharothrix Species 0.000 description 1
- 241001468274 Saccharothrix mutabilis Species 0.000 description 1
- 241000936887 Saccharothrix mutabilis subsp. capreolus Species 0.000 description 1
- 241000203415 Sphingobium chlorophenolicum Species 0.000 description 1
- 241000131972 Sphingomonadaceae Species 0.000 description 1
- 241001185305 Sphingomonadales Species 0.000 description 1
- 241000321601 Sphingomonas wittichii Species 0.000 description 1
- 241000187433 Streptomyces clavuligerus Species 0.000 description 1
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 1
- 241000970854 Streptomyces violaceusniger Species 0.000 description 1
- 241000204060 Streptomycetaceae Species 0.000 description 1
- 241000249496 Sulfolobaceae Species 0.000 description 1
- 101100434429 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) adh gene Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 241000204667 Thermoplasma Species 0.000 description 1
- 241000204673 Thermoplasma acidophilum Species 0.000 description 1
- 241000489996 Thermoplasma volcanium Species 0.000 description 1
- 241001074960 Thermoplasmata Species 0.000 description 1
- 241000204771 Thermoplasmataceae Species 0.000 description 1
- 241000205177 Thermoproteales Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000366307 Vulcanisaeta Species 0.000 description 1
- 241000366304 Vulcanisaeta distributa Species 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 241001148129 Yersinia ruckeri Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000002869 basic local alignment search tool Methods 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000011138 biotechnological process Methods 0.000 description 1
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000002029 lignocellulosic biomass Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012085 transcriptional profiling Methods 0.000 description 1
- 238000011222 transcriptome analysis Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000009105 vegetative growth Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
Definitions
- the present invention in general relates to the field of biotransformation of furanic compounds. Such biotransformations find utility in the production of furan-2,5-dicarboxylic acid (FDCA) and processing of lignocellulose containing material e.g. for the production of biofuels and biochemicals. More particular the present invention relates to novel genetically modified cells with improved characteristics for biocatalytic transformation of furanic compounds. A further aspect of the invention relates to a vector suitable for genetic modification of a host cell to improve its characteristics for biotransformation of furanic compounds. Other aspects of the invention relate to processes for biotransformation of 5-(hydroxymethyl)furan-2-carboxylic acid (HMF-acid) and its precursors with the use of the cell according to the invention.
- HMF-acid 5-(hydroxymethyl)furan-2-carboxylic acid
- Cupriavidus basilensis HMF14 has been isolated (Koopman et al. (2010a). This organism is capable of metabolizing furfural and 5-(hydroxymethyl)furan-2-carbaldehyde (HMF). The furfural and HMF degradation pathway of Cupriavidus basilensis HMF14 has been disclosed by Koopman et al. (2010a) together with the genes involved.
- HMF-acid 5-(hydroxymethyl)furan-2-carboxylic acid
- HMF-acid 5-(hydroxymethyl)furan-2-carboxylic acid
- HMF-acid bioconversion is beneficial for the elimination of HMF-acid and its furanic precursors from feedstocks wherein furanic compounds are considered to be detrimental, such as feedstocks for ethanologenic fermentations for the production of for example biofuels or for fermentations for the biological production of chemicals.
- improved HMF-acid bioconversion will improve bioproduction of a chemical where HMF-acid is a starting material or an intermediate, such as in FDCA bioproduction.
- a first object of the invention is a genetically modified cell comprising a first polynucleotide sequence coding for a first polypeptide having an amino acid sequence of SEQ ID. NO: 1, 2, 3 or 4 or its analogues/homologues and a second polynucleotide sequence coding for a second polypeptide having HMF-acid converting activity.
- the HMF-acid converting polypeptide may be the oxidoreductase encoded by the Cupriavidus basilensis HMF14 hmfH gene previously described (Koopman et al. 2010a and Koopman et al. 2010b).
- the genetically modified cell comprises a third polynucleotide sequence coding for a third polypeptide having an amino acid sequence of SEQ ID. NO: 19, 20, 21, 22, 23, 24, 25 or its analogues/homologues.
- Functional expression of the third amino acid sequences results in aldehyde dehydrogenase activity capable of converting furanic aldehydes.
- co-expression of the first polypeptide simultaneously with the oxidoreductase may also improve the quality of a whole-cell biocatalyst comprising the oxidoreductase with respect to biocatalytic FDCA production.
- the cell according to the invention is genetically modified by functional introduction of at least the first polynucleotide sequence.
- the cell is genetically modified by functional introduction of both the first and second polynucleotide sequence.
- the cell is genetically modified by functional introduction of the first and the third polynucleotide sequence.
- Functional introduction of all three of the first, the second and the third polynucleotide is a further alternative.
- a further aspect of the invention relates to a vector suitable for genetic modification of a host cell.
- the vector comprises a first polynucleotide sequence coding for a first polypeptide having an amino acid sequence of SEQ ID. NO.
- the vector may comprise a third polynucleotide sequence coding for a third polypeptide having an amino acid sequence of SEQ ID. NO: 19, 20, 21, 22, 23, 24, 25 or its analogues/homologues.
- a vector is suitable to obtain a genetically modified cell according to the invention.
- HMF-acid 5-(hydroxymethyl)furan-2-carboxylic acid
- a further aspect of the present invention is aimed at the use of a genetically modified cell according to the invention, for the biotransformation of furanic precursors to FDCA.
- FIG. 1 discloses a schematic representation of oxidative reactions of furanic compounds to 2,5-furan dicarboxylic acid.
- the following furanic compounds are presented: 1, HMF-alcohol; 2, HMF; 3, HMF-acid; 4, FFA; 5, FDCA.
- FIG. 2 discloses FDCA production and HMF-acid accumulation in HMF-fed cultures of P. putida S12_2642 ( FIG. 2 a ) and B38 ( FIG. 2 b ) ( ⁇ , FDCA (mM); ⁇ , HMF-acid (mM); ⁇ , cell dry weight (CDW; g/l); dotted line: HMF feed rate (ml 4 M solution/h))
- FIG. 3 discloses specific FDCA productivity at various time points during the fed-batch processes presented in FIG. 2 (Dark: P. putida S12_2642; Light: P. putida S12_B38).
- FIG. 4 discloses FDCA production and HMF-acid accumulation in shake-flask experiments with P. putida S12_B38 ( FIG. 4 a ) and B51 ( FIG. 4 b ) ( ⁇ , HMF (mM); ⁇ , FDCA (mM); ⁇ , HMF-acid (mM); ⁇ , cell dry weight (CDW; g/l));
- FIG. 5 discloses FDCA production and HMF-acid accumulation in HMF-fed high-cell density culture of P. putida S12_B38 starting at high cell density ( ⁇ , HMF; ⁇ , FDCA (mM); ⁇ , HMF-acid (mM); ⁇ , cell dry weight (CDW; g/l); dotted line: HMF feed rate (ml 4 M solution/h)).
- FIG. 6 discloses the accumulation of FDCA, FFA and HMF-acid in HMF containing shake-flask cultures of P. putida S12_B38 (co-expressed HmfH and HmfT1; A); S12_B97 (co-expressed HmfH, HmfT1 and aldehyde dehydrogenase; B); and S12_B101 (co-expressed HmfH and aldehyde dehydrogenase; C).
- SEQ ID NO: 1 sets out the amino acid sequence of HmfT1 from Cupriavidus basilensis HMF14.
- the sequence has GenBank accession number ADE20411.1.
- SEQ ID NO: 2 sets out the amino acid sequence of HmfT2 from Cupriavidus basilensis HMF14.
- the sequence has GenBank accession number ADE20404.1.
- the sequence has GenBank accession number ACB26689.1.
- SEQ ID NO: 4 sets out the amino acid sequence of the protein product from the saci_2058 gene from Sulfolobus acidocaldarius DSM 639.
- the sequence has GenBank accession number AAY81352.1.
- SEQ ID NO: 5 sets out the amino acid sequence of HmfH from Cupriavidus basilensis HMF14.
- the sequence has GenBank accession number ADE20408.1.
- SEQ ID NO: 6 sets out the amino acid sequence of the protein product from the blr0367 gene from Bradyrhizobium japonicum USDA 110.
- the sequence has GenBank accession number BAC45632.1.
- SEQ ID NO: 7 sets out the coding sequence of hmfT1 from Cupriavidus basilensis HMF14.
- SEQ ID NO: 8 sets out the coding sequence of hmfT2 from Cupriavidus basilensis HMF14.
- SEQ ID NO: 10 sets out the coding sequence of the saci_2058 gene from Sulfolobus acidocaldarius DSM 639.
- SEQ ID NO: 11 sets out the coding sequence of hmfH from Cupriavidus basilensis HMF14.
- SEQ ID NO: 12 sets out the coding sequence of the blr0367 gene from Bradyrhizobium japonicum USDA 110.
- SEQ ID NO: 13-18 set out the sequences of various synthetic primers. Restriction locations (underlined), start and stop (reverse complement) codons (italic) and putative ribosome binding sites (lower case) are indicated.
- the FN23 primer was designed just upstream of the start codon of hmfH.
- SEQ ID NO: 13 sets out the nucleotide sequence of synthetic DNA primer hmfT1 (f)
- SEQ ID NO: 14 sets out the nucleotide sequence of synthetic DNA primer hmfT1 (r)
- SEQ ID NO: 15 sets out the nucleotide sequence of synthetic DNA primer FN23.
- SEQ ID NO: 16 sets out the nucleotide sequence of synthetic DNA primer FN24.
- SEQ ID NO: 17 sets out the nucleotide sequence of synthetic DNA primer mrad (f).
- SEQ ID NO: 18 sets out the nucleotide sequence of synthetic DNA primer mrad (r).
- SEQ ID NO: 19 sets out the amino acid sequence of the aldehyde dehydrogenase Adh from Cupriavidus basilensis HMF14.
- SEQ ID NO: 20 sets out the amino acid sequence having Genbank accession number: YP_003609156.1.
- SEQ ID NO: 21 sets out the amino acid sequence having Genbank accession number: ZP_02881557.1.
- SEQ ID NO: 22 sets out the amino acid sequence having Genbank accession number: YP_003451184.1.
- SEQ ID NO: 23 sets out the amino acid sequence having Genbank accession number: ACA09737.1.
- SEQ ID NO: 24 sets out the amino acid sequence having Genbank accession number: YP_530742.1.
- SEQ ID NO: 25 sets out the amino acid sequence having Genbank accession number: YP_001541929.1.
- SEQ ID NO: 26 sets out the polynucleotide sequence of adh encoding the aldehyde dehydrogenase Adh from Cupriavidus basilensis HMF14.
- SEQ ID NO: 27 sets out the polynucleotide sequence encoding the amino acid sequence having Genbank accession number: YP_003609156.1.
- SEQ ID NO: 28 sets out the polynucleotide sequence encoding the amino acid sequence having Genbank accession number: ZP_02881557.1.
- SEQ ID NO: 29 sets out the polynucleotide sequence encoding the amino acid sequence having Genbank accession number: YP_003451184.1.
- SEQ ID NO: 30 sets out the polynucleotide sequence encoding the amino acid sequence having Genbank accession number: ACA09737.1.
- SEQ ID NO: 31 sets out the polynucleotide sequence encoding the amino acid sequence having Genbank accession number: YP_530742.1.
- SEQ ID NO: 32 sets out the polynucleotide sequence encoding the amino acid sequence having Genbank accession number: YP_001541929.1.
- SEQ ID NO: 33 sets out the nucleotide sequence of synthetic DNA primer FN13: 5′-AT GCGGCCGC AACAaggagAAGATGGAATGAACG-3′ (underlined sequence: NotI restriction site; start codon (ATG) of aldehyde dehydrogenase encoding gene in italics; putative ribosome binding site (RBS) in lower case)
- SEQ ID NO: 34 sets out the nucleotide sequence of synthetic DNA primer FN14: 5′-AT GCGGCCGC GCGTCGGGGTCGGTGCTA-3′ (underlined sequence: NotI restriction site; stop codon (reverse complement strand) in italics).
- an element may mean one element or more than one element.
- Furanic compounds are herein understood to be any compound having a furan ring.
- the furanic compound is a compound that may be oxidized to 2,5-furandicarboxylic acid.
- Furanic compounds relevant within the context of this invention include [5-(hydroxymethyl)furan-2-yl]methanol (“HMF-alcohol”), 5-(hydroxymethyl)furan-2-carbaldehyde (“HMF”), 5-(hydroxymethyl)furan-2-carboxylic acid (“HMF-acid”), 5-formylfuran-2-carboxylic acid (“FFA”), furan-2,5-dicarbaldehyde (DFF) and furan-2,5-dicarboxylic acid (“FDCA”).
- HMF-alcohol [5-(hydroxymethyl)furan-2-yl]methanol
- HMF 5-(hydroxymethyl)furan-2-carbaldehyde
- HMF-acid 5-(hydroxymethyl)furan-2-carboxylic acid
- FFA furan-2
- the furan ring or any of its substitutable side groups may be substituted, e.g., with OH, C1-C10 alkyl, alkyl, allyl, aryl or RO-ether moiety, including cyclic groups, on any available position in the furan ring.
- the chemical structures of a number of relevant furanic compounds are presented below.
- polynucleotide includes poly deoxyribonucleic acids (DNA) and poly ribonucleic acids (RNA) and the term may refer to either DNA or RNA.
- DNA poly deoxyribonucleic acids
- RNA poly ribonucleic acids
- the skilled person will be aware of the differences in stability of DNA and RNA molecules. Thus the skilled person will be able to understand from the context of the use of the term “polynucleotide” which of the forms of polynucleotide (DNA and/or RNA) is suitable.
- sequence “similarity” is used it embraces sequence “identity” and “conservative changes”.
- sequence identity is known to the skilled person.
- sequences are aligned for optimal comparison purposes (e.g., gaps can be introduced in the sequence of a first amino acid or nucleic acid sequence for optimal alignment with a second amino or nucleic acid sequence).
- alignment may be carried out over the full lengths of the sequences being compared.
- the alignment may be carried out over a shorter comparison length, for example over about 20, about 50, about 100 or more nucleic acids/bases or amino acids.
- the amino acid residues or nucleotides at corresponding amino acid positions or nucleotide positions are then compared.
- a position in the first sequence is occupied by the same amino acid residue or nucleotide as the corresponding position in the second sequence, then the molecules are identical at that position.
- the two sequences being compared are of the same or substantially the same length.
- the percentage of “conservative changes” may be determined similar to the percentage of sequence identity. However, in this case changes at a specific location of an amino acid or nucleotide sequence that are likely to preserve the functional properties of the original residue are scored as if no change occurred.
- amino acid sequences the relevant functional properties are the physico-chemical properties of the amino acids.
- a conservative substitution for an amino acid in a polypeptide of the invention may be selected from other members of the class to which the amino acid belongs.
- an amino acid belonging to a grouping of amino acids having a particular size or characteristic such as charge, hydrophobicity and hydrophilicity
- nonpolar (hydrophobic) amino acids include alanine, leucine, isoleucine, valine, proline, phenylalanine, tryptophan, and tyrosine.
- Polar neutral amino acids include glycine, serine, threonine, cysteine, tyrosine, asparagine and glutamine.
- the positively charged (basic) amino acids include arginine, lysine and histidine.
- the negatively charged (acidic) amino acids include aspartic acid and glutamic acid. Conservative substitutions include, for example, Lys for Arg and vice versa to maintain a positive charge; Glu for Asp and vice versa to maintain a negative charge; Ser for Thr so that a free —OH is maintained; and Gln for Asn to maintain a free —NH 2 .
- nucleotide sequences the relevant functional properties is mainly the biological information that a certain nucleotide carries within the open reading frame of the sequence in relation to the transcription and/or translation machinery. It is common knowledge that the genetic code has degeneracy (or redundancy) and that multiple codons may carry the same information in respect of the amino acid for which they code.
- amino acid leucine is coded by UUA, UUG, CUU, CUC, CUA, CUG codons (or TTA, TTG, CTT, CTC, CTA, CTG for DNA), and the amino acid serine is specified by UCA, UCG, UCC, UCU, AGU, AGC (or TCA, TCG, TCC, TCT, AGT, AGC for DNA). Nucleotide changes that do not alter the translated information are considered conservative changes.
- the skilled person will be aware of the fact that several different computer programs, using different mathematical algorithms, are available to determine the identity between two sequences. For instance, use can be made of a computer program employing the Needleman and Wunsch algorithm (Needleman et al. (1970)). According to an embodiment the computer program is the GAP program in the Accelerys GCG software package (Accelerys Inc., San Diego U.S.A). Substitution matrices that may be used are for example a BLOSUM 62 matrix or a PAM250 matrix, with a gap weight of 16, 14, 12, 10, 8, 6, or 4 and a length weight of 1, 2, 3, 4, 5, or 6. The skilled person will appreciate that all these different parameters will yield slightly different results but that the overall percentage identity of two sequences is not significantly altered when using different algorithms.
- the percent identity between two nucleotide sequences is determined using the GAP program in the Accelrys GCG software package (Accelerys Inc., San Diego U.S.A)
- Accelrys GCG software package Accelrys Inc., San Diego U.S.A
- a NWSgapdna CMP matrix and a gap weight of 40, 50, 60, 70, or 80 and a length weight of 1, 2, 3, 4, 5, or 6 is used.
- the percent identity of two amino acid or nucleotide sequences is determined using the algorithm of E. Meyers and W. Miller (Meyers et al. (1989)) which has been incorporated into the ALIGN program (version 2.0) (available at the ALIGN Query using sequence data of the Genestream server IGH Montpellier France http://vega.igh.cnrs.fr/bin/align.guess.cgi) using a PAM120 weight residue table, a gap length penalty of 12 and a gap penalty of 4.
- BLAST Basic Local Alignment Tool
- BLAST queries are performed with the following parameters.
- the percentage of “conservative changes” may be determined similar to the percentage of sequence identity with the aid of the indicated algorithms and computer programmes.
- Some computer programmes, e.g., BLASTp, present the number/percentage of positives ( similarity) and the number/percentage of identity.
- the genetically modified cell according to the invention comprises a first polynucleotide coding for a first polypeptide.
- the first polypeptide comprises an amino acid sequence having at least 45%, preferably at least 60%, such as at least 70%, more preferably at least 80%, such as 90%, most preferably at least 95% sequence similarity with an amino acid sequence of SEQ ID NO: 1, 2, 3 or 4.
- sequence similarity may be expressed as at least, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or at least 99% similarity.
- indicated percentages similarity may be percentages identity.
- the first polypeptide may comprise the amino acid sequence as set out in any of SEQ ID NO: 1, 2, 3 or 4.
- Such a polypeptide is capable of providing an improvement with respect to HMF-acid bioconversion.
- HMF-acid transport capabilities By transportation of HMF-acid into the cell by the first polypeptide it becomes better available for intracellular conversion. Thus HMF-acid bioconversion may be improved.
- HmfT1 SEQ ID NO: 1
- HmfT2 SEQ ID NO: 2
- HmfT2 (SEQ ID NO: 2) has over 90% similarity with HmfT1 (SEQ ID NO: 1). The level of identity is 87%.
- a similar functionality for the protein product of the saci_2058 gene from Sulfolobus acidocaldarius DSM 639 may be expected based on a CLUSTALW2 multiple sequence alignment with transporters from different functional families.
- the Sulfolobus transporter forms a cluster with HmfT1 (SEQ ID NO: 1) and Mrad2831_4728 (SEQ ID NO: 3).
- HmfT1 SEQ ID NO: 1
- Mrad2831_4728 SEQ ID NO: 3
- analysis of the S. acidocaldarius genome has shown that the transporter gene saci_2058 is flanked by genes that encode similar functionalities as the hmf gene clusters, respectively, the type of activities that are expected in degradation of HMF(-like compounds).
- Saci_2057 alcohol dehydrogenase
- Saci_2059/2060 aromatic ring dioxygenase
- Saci_2062 acyl-CoA synthetase (functionally comparable to hmfD)
- Saci_2063, enoyl-CoA hydratase (functionally comparable with hmfE)
- Saci_2064 aldehyde oxidase/xanthine dehydrogenase (functionally comparable to hmfABC).
- the first polypeptide may be encoded by a first polynucleotide sequence having at least 45%, preferably at least 60%, such as at least 70%, more preferably at least 80%, such as 90%, most preferably at least 95% sequence similarity with a polynucleotide sequence set out in SEQ ID NO: 7, 8, 9 or 10.
- Suitable alternative levels of similarity of the first polynucleotide with a sequence set out in SEQ ID NO: 7, 8, 9 or 10 may be at least 66%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or at least 99% similarity.
- the indicated percentages similarity may be percentages identity.
- the first polypeptide may be coded by a polynucleotide sequence as set out in SEQ ID NO 7, 8, 9 or 10.
- the first polypeptide or the polynucleotide coding for the first polypeptide may be isolated from an organism, preferably a microorganism that expresses the first polypeptide under certain growth conditions.
- the microorganism may be capable of using HMF-acid or related furanic substances, such as HMF or HMF-alcohol, as carbon source, but this is not necessary.
- gene libraries can be screened to isolate alternative polynucleotides which are suitable.
- the libraries may be constructed from microorganisms from the superkingdom of Bacteria. These microorganisms may belong to the phylum of Proteobacteria, more specifically to the class of Alphaproteobacteria or Betaproteobacteria.
- the Alphaproteobacteria may belong to the order of Rhizobiales, to the families of Bradyrhizobiaceae or Methylobacteriaceae.
- the Bradyrhizobiaceae may belong to the genus of Bradyrhizobium , e.g., Bradyrhizobium japonicum , or to the genus of Afipia .
- the Methylobacteriaceae may belong to the genus of Methylobacterium , e.g., Methylobacterium nodulans or Methylobacterium radiotolerans .
- the Betaproteobacteria may belong to the order of Burkholderiales, more specifically the family of Burkholderiaceae.
- the bacteria may also belong to the phylum of Firmicutes, more specifically the class of Bacilli, more specifically the order of Bacillales.
- the Bacillales may belong to the family of Bacillaceae, more specifically to the genus Geobacillus , e.g., Geobacillus kaustophilus .
- the microorganisms may belong to the superkingdom of Archaea, more specifically the phylum of Euryarchaeota, or the phylum of Crenarchaeota.
- the Euryarchaeota may belong to an unclassified genus, e.g., Cand. Parvarchaeum acidiphilum , or to the class of Thermoplasmata, more specifically the order of Thermoplasmatales.
- Thermoplasmatales may belong to the family of Thermoplasmataceae, more specifically the genus Thermoplasma , e.g., Thermoplasma acidophilum or Thermoplasma volcanium .
- the Crenarchaeota may belong to the class of Thermoprotei, more specifically the order of Sulfolobales.
- the Sulfolobales may belong to the family of Sulfolobaceae, more specifically the genus Sulfolobus , e.g., Sulfolobus acidocaldarius, Sulfolobus islandicus, Sulfolobus solfataricus , or Sulfolobus tokodaii ; or to the genus of Metallosphaera , e.g., Metallosphaera sedula .
- Thermoprotei may also belong to the order of Thermoproteales, family of Thermoproteaceae.
- Thermoproteaceae may belong to the genus Vulcanisaeta , e.g., Vulcanisaeta distributa ; or to the genus Caldivirga , e.g., Caldivirga maquilingensis.
- the first polypeptide and/or the first polynucleotide coding for the first polypeptide is isolated from Cupriavidus basilensis HMF14 (Wierckx et al. 2010).
- the first polypeptide and/or the first polynucleotide coding for the first polypeptide may be isolated from Methylobacterium radiotolerans.
- synthesized sequences coding for the first polypeptide may be obtained from commercial sources, as gene synthesis is becoming increasingly available. Synthetic sequences may be purchased for example from Geneart A.G. (Regensburg, Germany) or from Genscript USA Inc. (Piscataway, N.J., USA) to name but a few.
- the cell according to the invention is genetically modified by functional introduction of the first polynucleotide.
- functional introduction of a polynucleotide is meant, an introduction of said polynucleotide in a cell, such that said cell acquires the possibility to express a functional polypeptide product of the polynucleotide.
- Methods and techniques for functional introduction of polynucleotides in host cells are within the general knowledge of the skilled person.
- the genetically modified cell according to the invention comprises a second polynucleotide coding for a second polypeptide.
- the second polypeptide has HMF-acid converting activity and may be selected from any polypeptide capable of converting HMF-acid to a product.
- the inventors have observed that bioconversion of HMF-acid by the HMF-acid converting second polypeptide, is effectively improved by expression of the first polypeptide in a cell.
- the second polypeptide is an HMF-acid converting oxidoreductase.
- This HMF-acid converting oxidoreductase may comprise an amino acid sequence set out in SEQ ID NO: 5 or 6 or a variant polypeptide thereof having at least 45%, preferably at least 60%, such as at least 70%, more preferably at least 80%, such as 90%, most preferably at least 95% sequence similarity with the amino acid sequence set out in SEQ ID NO 5 or 6.
- sequence similarity may be at least, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or at least 99% similarity.
- indicated percentages similarity may be percentages identity.
- the second polypeptide may comprise the amino acid sequence as set out in any of SEQ ID NO: 5 or 6.
- the HMF-acid converting oxidoreductase of SEQ ID NO: 5 was previously disclosed by Koopman et al. (2010a) and Koopman et al. (2010b) and designated HmfH.
- the HMF-acid converting oxidoreductase of SEQ ID NO: 6 may be isolated from Bradyrhizobium japonicum USDA 110 and corresponds to the translated protein product of the blr0367 gene.
- B. japonicum USDA 110 contains homologues for all HMF/furfural utilization genes from C. basilensis HMF14 in its genome (Koopman et al. 2010a).
- the translated product of the blr0367 gene is the protein of B.
- the invention is exemplified with reference to a number of HMF-acid converting oxidoreductases it should be noted that within the invention it is expressly permitted that the second polypeptide is a different HMF-acid converting oxidoreductase or yet a different HMF-acid converting polypeptide not having oxidoreductase activity.
- the second polypeptide may be encoded by a second polynucleotide sequence having at least 45%, preferably at least 60%, such as at least 70%, more preferably at least 80%, such as 90%, most preferably at least 95% sequence similarity with a polynucleotide sequence set out in SEQ ID NO: 11 or 12.
- Suitable alternative levels of similarity of the first polynucleotide with a sequence set out in SEQ ID NO: 11 or 12 may be at least 66%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or at least 99% similarity.
- the indicated percentages similarity may be percentages identity.
- the second polypeptide may be coded by a polynucleotide sequence as set out in SEQ ID NO 11 or 12.
- gene libraries can be screened to isolate polynucleotides which are suitable.
- the libraries may be constructed from microorganisms from the superkingdom of Bacteria. These microorganisms may belong to the phylum of Proteobacteria, more specifically to the class of Alphaproteobacteria, Betaproteobacteria, or Gammaproteobacteria.
- the Alphaproteobacteria may belong to the order of Rhizobiales, or the order of Sphingomonadales.
- the Rhizobiales may belong to the family of Methylobacteriaceae, e.g., an organism from the genus Methylobacterium such as M. nodulans or M.
- Rhizobiaceae may belong to the Rhizobium/Agrobacterium group, more specifically to the genus Rhizobium , such as R. leguminosarum or R. leguminosarum bv. trifolii . They may also belong to the genus Agrobacterium , such as A. radiobacter .
- the Rhizobiaceae may also belong to the family of Bradyrhizobiaceae, more specifically the genus of Bradyrhizobium , such as B. japonicum .
- Sphingomonedales may belong to the family of Sphingomonadaceae, more specifically to the genus of Sphingomonas , such as S. wittichii or S. chlorophenolicum .
- the Betaproteobacteria may belong to the order of the Methylophilales, or the order of Burkholderiales.
- the Methylophilales may belong to the family of Methylophilaceae, e.g., an organism from the genus Methylovorus .
- the Burkholderiales may belong to the family of Burkholderiaceae, e.g., an organism from the genus Cupriavidus , such as Cupriavidus basilensis .
- Burkholderia may also belong to the genus Burkholderia , such as Burkholderia phytofirmans.
- B. phymatum, B. graminis, B. xenovorans , or B. cenocepacia or to the family of Oxalobacteraceae, genus of Janthinobacterium .
- the Gammaproteobacteria may belong to the order of Enterobacteriales, family of Enterobacteriaceae, genus of Yersinia such as Yersinia ruckeri .
- the microorganisms may furthermore be bacteria of the phylum of Actinobacteria, class of Actinobacteria, subclass of Actinobacteridae, order of Actinomycetales.
- the Actinomycetales may belong to the suborder of Streptomycineae, Pseudonocardineae, or Micromonosporineae.
- the Streptomycineae may belong to the family of Streptomycetaceae, more specifically the genus Streptomyces , such as S. violaceusniger, S. hygroscopicus , or S. clavuligerus .
- the Pseudonocardineae may belong to the family of Pseudonocardiaceae, more specifically the genus of Saccharopolyspora such as S. erythraea ; or to the family of Actinosynnemataceae, more specifically to the genus of Saccharothrix such as S. mutabilis , or S. mutabilis subsp. capreolus , or to the genus Actinosynnema , such as A. mirum .
- the Micromonosporineae may belong to the family of Micromonosporaceae, more specifically the genus of Micromonospora.
- the skilled person may obtain synthesized sequences coding for the second polypeptide from commercial sources as already indicated in the section discussing the first polypeptide.
- the genetically modified cell according to the invention comprises a third polynucleotide coding for a third polypeptide.
- the third polypeptide comprises an amino acid sequence having at least 45%, preferably at least 60%, such as at least 70%, more preferably at least 80%, such as 90%, most preferably at least 95% sequence similarity with an amino acid sequence of SEQ ID NO: 19, 20, 21, 22, 23, 24 or 25.
- the sequence similarity may be expressed as at least, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or at least 99% similarity.
- the indicated percentages similarity may be percentages identity.
- the first polypeptide may comprise the amino acid sequence as set out in any of SEQ ID NO: 19, 20, 21, 22, 23, 24 or 25.
- the amino acid sequence of SEQ ID NO: 19 is a preferred selection of the third polypeptide. This amino acid sequence was recently published in WO2011/026906 (SEQ ID NO:15).
- the third polypeptide may be encoded by a third polynucleotide sequence having at least 45%, preferably at least 60%, such as at least 70%, more preferably at least 80%, such as 90%, most preferably at least 95% sequence similarity with a polynucleotide sequence set out in SEQ ID NO: 26, 27, 28, 29, 30, 31 or 32.
- the third polypeptide is encoded by a polynucleotide sequence set out in SEQ ID NO 26 or a homologue having the indicated sequence similarity with the polynucleotide sequence set out in SEQ ID NO: 26.
- the polynucleotide sequence of SEQ ID NO: 26 was recently published in WO2011/026906 (SEQ ID NO:16).
- Suitable alternative levels of similarity of the third polynucleotide with a sequence set out in SEQ ID NO: 26, 27, 28, 29, 30, 31 or 32 may be at least 66%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or at least 99% similarity.
- the indicated percentages similarity may be percentages identity.
- the third polypeptide may be coded by a polynucleotide sequence as set out in SEQ ID NO 26, 27, 28, 29, 30, 31 or 32.
- Isolation and further manipulation of the third polypeptide and the corresponding third polynucleotide may be performed in general as is discussed above and hereafter for the first polypeptide and the corresponding first polypeptide.
- vectors including cloning and expression vectors, comprising the first and second polynucleotide or a functional equivalent thereof and methods of growing, transforming or transfecting such vectors in a suitable host cell, for example under conditions in which expression of a polypeptide of the invention occurs.
- vector refers to a nucleic acid molecule capable of transporting another nucleic acid to which it has been linked.
- the first and second polynucleotide and optionally the third polynucleotide can be incorporated into a recombinant replicable vector, for example a cloning or expression vector.
- the vector may be used to replicate the nucleic acid in a compatible host cell.
- the invention provides a method of making polynucleotides of the invention by introducing a polynucleotide of the invention into a replicable vector, introducing the vector into a compatible host cell, and growing the host cell under conditions which bring about replication of the vector.
- the vector may be recovered from the host cell. Suitable host cells are described below.
- the vector into which the expression cassette or polynucleotide of the invention is inserted may be any vector which may conveniently be subjected to recombinant DNA procedures, and the choice of the vector will often depend on the host cell into which it is to be introduced.
- a vector according to the invention may be an autonomously replicating vector, i.e. a vector which exists as an extra-chromosomal entity, the replication of which is independent of chromosomal replication, e.g., a plasmid.
- the vector may be one which, when introduced into a host cell, is integrated into the host cell genome and replicated together with the chromosome (s) into which it has been integrated.
- vector refers to a circular double stranded DNA loop into which additional DNA segments can be ligated.
- viral vector Another type of vector is a viral vector, wherein additional DNA segments can be ligated into the viral genome.
- Certain vectors are capable of autonomous replication in a host cell into which they are introduced (e.g., bacterial vectors having a bacterial origin of replication and episomal mammalian vectors).
- Other vectors e.g., non-episomal mammalian vectors
- certain vectors are capable of directing the expression of genes to which they are operatively linked.
- expression vectors are referred to herein as “expression vectors”.
- expression vectors of utility in recombinant DNA techniques are often in the form of plasmids.
- the terms “plasmid” and “vector” can be used interchangeably herein as the plasmid is the most commonly used form of vector.
- the invention is intended to include such other forms of expression vectors, such as cosmid, viral vectors (e.g., replication defective retroviruses, adenoviruses and adeno-associated viruses), phage vectors and transposons and plasposons, which serve equivalent functions.
- the first and second polynucleotide sequence are located on a single vector.
- This vector optionally further comprising the third polynucleotide sequence.
- the use of a vector comprising the first and second polynucleotide sequence (and optionally further comprising the third polynucleotide sequence) greatly simplifies construction of genetically modified cells functionally expressing the first and second polypeptide (optionally together with the third polypeptide).
- genetically modified cells functionally expressing the first and second polypeptide may be obtained via various other transformation schemes involving alternative vectors.
- functional introduction of the second polynucleotide sequence is not a requirement.
- functional introduction of the third polynucleotide sequence is not a requirement.
- the genetically modified cell according to the invention may be constructed from any suitable host cell.
- the host cell may be an unmodified cell or may already be genetically modified.
- the cell may be a prokaryote cell, a eukaryote cell, a plant cell or an animal cell. In such a cell one or more genes may be deleted, knocked-out or disrupted in full or in part, wherein optionally one or more genes encode for protease.
- the host cell according to the invention is a eukaryotic host cell.
- the eukaryotic cell is a mammalian, insect, plant, fungal, or algal cell.
- Preferred mammalian cells include, e.g., Chinese hamster ovary (CHO) cells, COS cells, 293 cells, PerC6 cells, and hybridomas.
- Preferred insect cells include e.g. Sf9 and Sf21 cells and derivatives thereof.
- the eukaryotic cell is a fungal cell, i.e., a yeast cell, such as Candida, Hansenula, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces , or Yarrowia strain.
- the eukaryotic cell is Kluyveromyces lactis, Saccharomyces cerevisiae, Hansenula polymorpha, Yarrowia lipolytica, Pichia stipitis and Pichia pastoris , or a filamentous fungal cell.
- the eukaryotic cell is a filamentous fungal cell.
- “Filamentous fungi” include all filamentous forms of the subdivision Eumycota and Oomycota (as defined by Hawksworth et al., (1995)). The filamentous fungi are characterized by a mycelial wall composed of chitin, cellulose, glucan, chitosan, mannan, and other complex polysaccharides. Vegetative growth is by hyphal elongation and carbon catabolism is obligately aerobic.
- Filamentous fungal strains include, but are not limited to, strains of Acremonium, Agaricus, Aspergillus, Aureobasidium, Chrysosporium, Coprinus, Cryptococcus, Filibasidium, Fusarium, Humicola, Magnaporthe, Mucor, Myceliophthora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Piromyces, Phanerochaete, Pleurotus, Schizophyllum, Talaromyces, Thermoascus, Thielavia, Tolypocladium , and Trichoderma.
- Preferred filamentous fungal cells belong to a species of an Aspergillus, Chrysosporium, Penicillium, Talaromyces or Trichoderma genus, and most preferably a species selected from Aspergillus niger, Aspergillus awamori, Aspergillus foetidus, Aspergillus sojae, Aspergillus fumigatus, Talaromyces emersonii, Aspergillus oryzae, Chrysosporium lucknowense, Trichoderma reesei or Penicillium chrysogenum.
- the host cell according to the invention is a prokaryotic cell.
- the prokaryotic host cell is bacterial cell.
- the term “bacterial cell” includes both Gram-negative and Gram-positive microorganisms. Suitable bacteria may be selected from, e.g., the genera Escherichia, Anabaena, Caulobacter, Gluconobacter, Rhodobacter, Pseudomonas, Paracoccus, Bacillus, Brevibacterium, Corynebacterium, Rhizobium ( Sinorhizobium ), Bradyrhizobium, Flavobacterium, Klebsiella, Enterobacter, Lactobacillus, Lactococcus, Methylobacterium, Staphylococcus, Streptomyces, Zymomonas, Acetobacter, Streptococcus, Bacteroides, Selenomonas, Megasphaera, Burkholderia, Cupriavidus, Ralstonia, Methy
- the bacterial cell is selected from the group consisting of Bacillus subtilis, Bacillus amyloliquefaciens, Bacillus licheniformis, Bacillus puntis, Bacillus megaterium, Bacillus halodurans, Bacillus pumilus, Gluconobacter oxydans, Caulobacter crescentus, Methylobacterium extorquens, Methylobacterium radiotolerans, Methylobacterium nodulans, Rhodobacter sphaeroides, Pseudomonas zeaxanthinifaciens, Pseudomonas putida, Pseudomonas putida S12, Paracoccus denitrificans, Escherichia coli, Corynebacterium glutamicum, Staphylococcus carnosus, Streptomyces lividans, Sinorhizobium meliloti, Bradyrhizo
- a highly preferred host cell is Pseudomonas putida S12.
- functional expression of the hmfH gene from Cupriavidus basilensis HMF14 has proven effective for introducing HMF oxidative capacity, resulting in FDCA production from this substrate.
- the selection of the host cell may be made according to such use.
- Particularly preferred are those hosts that are suitable for conversion of lignocellulosic feed stocks and those which are resistant to the conditions preferred for the production of furanic compounds, such as FDCA.
- the skilled person will have to his availability suitable means and methods to functionally introduce the first and optionally the second poly nucleotide into any of the mentioned host cells.
- the genetically engineered cell according to the invention has an improved HMF-acid biotransformation.
- Improved HMF-acid bioconversion is beneficial for the elimination of HMF-acid and its furanic precursors from feedstocks wherein furanic compounds are considered to be detrimental, such as feedstocks for ethanologenic fermentations for the production of biofuels and biochemicals.
- improved HMF-acid bioconversion will improve bioproduction of chemical where HMF-acid is a starting material or an intermediate, such as in FDCA bioproduction.
- the cell according to the invention will be capable of performing a biological oxidation reaction.
- the oxidation reaction is herein one or more reactions of an oxidant with HMF-acid in the presence of the oxidoreductase.
- a preferred oxidation reaction is the production of FDCA, wherein HMF-acid is converted to FDCA, by reaction with an oxidant in the presence of a HMF-acid converting oxidoreductase.
- Bioconversions of furanic compounds to FDCA, wherein HMF-acid is an intermediate, have been disclosed in the prior art, for example using HMF as a starting material (see Koopman et al. 2010a and Koopman et al. 2010b). Such bioconversions will be improved if they are performed by a cell according to the invention.
- HMF-acid may be generated in situ from one or more furanic precursors by the cell of the invention or any other cell present. With in situ generation is meant that the HMF-acid is not added from outside the system. Instead HMF-acid is generated within the system via one or more bioconversions that convert furanic precursors to HMF-acid.
- the furanic precursor of HMF-acid may be chosen from the group consisting of 5-(hydroxymethyl)furan-2-carbaldehyde (HMF), furan-2,5-dicarbaldehyde (DFF) and [5-(hydroxymethyl)furan-2-yl]methanol (HMF alcohol) and preferably the furanic precursor is HMF.
- HMF 5-(hydroxymethyl)furan-2-carbaldehyde
- DFF furan-2,5-dicarbaldehyde
- HMF alcohol [5-(hydroxymethyl)furan-2-yl]methanol
- HMF may be obtained from one or more hexose sugars by acid-catalyzed dehydration, as is known in the art.
- the hexose sugars may be obtained from biomass, preferably lignocellulosic biomass.
- the oxidation reaction may comprise a number of consecutive oxidation reaction steps resulting in a product e.g. the oxidation of HMF-acid to FFA and further the oxidation of FFA to FDCA. Examples of oxidation reactions are given in FIG. 1 .
- the oxidation reactions are preferably conducted at relatively mild temperature, i.e. 10-80° C., more preferably 20-45° C., most preferably around from 25-40° C. It is preferred to conduct the reaction at a pH where FDCA is either in a neutral form or in a fully dissociated form, such that salt formation may be controlled.
- FDCA FDCA
- the pH during the reaction may be from pH 1 to 6, preferably from pH 1 to 4, most preferably from pH 1 to 3.
- the pH during the reaction may be from pH 5 to 9, preferably from pH 5 to 8, most preferably from pH 5 to 7.
- the skilled person will understand that the requirements of the host cell will also influence the selection of a suitable pH value for the process.
- pH values that are suitable for the various host cells that are suitable within the present invention is within the ambit of the skilled person and may be derived from standard text books.
- Pseudomonas putida including Pseudomonas putida S12, the preferred pH range is from pH 5 to 7.
- the reaction time may be 6-150 h, with the addition of oxygen from an oxygen source, such as molecular oxygen, or water, or a different source of oxygen depending on the requirements of the furanic oxidizing enzyme.
- oxygen source such as molecular oxygen, or water
- Air may be used conveniently as a source of molecular oxygen.
- the reactor may be any suitable (aerated) bioreactor. It may be operated in batch, continuously or fed-batch operation.
- the cells may be separated from the broth by established methods and re-used.
- Oxidation products such as FDCA, HMF-acid, etc. may be recovered from the reaction mixture by (acid) precipitation and subsequent cooling crystallisation, and separation of the crystallized oxidation product, e.g., crystallized FDCA.
- other recovery methods are suitable, such as but not limited to acid precipitation and solvent extraction, as known in the art.
- HMF-acid converting polypeptide may be any polypeptide having HMF-converting activity presently known or yet to be discovered.
- a further aspect of the present invention is aimed at the use of a genetically modified cell according to the invention, for the biotransformation of furanic precursors to FDCA.
- the furanic precursors may in particular be selected from 5-(hydroxymethyl)furan-2-carbaldehyde (HMF), [5-(hydroxymethyl)furan-2-yl]methanol (HMF alcohol), furan-2,5-dicarbaldehyde (DFF), 5-(hydroxymethyl)furan-2-carboxylic acid (HMF-acid) or 5-formylfuran-2-carboxylic acid (FFA).
- HMF is a selected furanic precursor.
- HMF-acid may be an intermediate in the bioconversion of HMF to FDCA.
- Escherichia coli strains DH5 ⁇ or TOP10 were used for general cloning purposes.
- C. basilensis or M. radiotolerans genes either the pUCP22-derived pJT′mcs (Koopman et al., 2010a) or pJNNmcs(t) (Wierckx et al., 2008), or the pBBR1MCS-derived pBT′mcs (Koopman et al., 2010a) was used.
- pJT′mcs and pBT′mcs the expression of the target gene is driven from the constitutive tac promoter.
- pJNNmcs(t) the expression is driven from the salicylate inducible NagR/P nagAa expression cassette.
- MM Mineral salts medium
- MM contained the following (per liter of demineralized water): 3.88 g of K 2 HPO 4 , 1.63 g of NaH 2 PO 4 , 2.0 g of (NH 4 ) 2 SO 4 , 0.1 g of MgCl 2 .6H 2 O, 10 mg of EDTA, 2 mg of ZnSO 4 .7H 2 0, 1 mg of CaCl 2 .2H 2 O, 5 mg of FeSO 4 .7H 2 0, 0.2 mg of Na 2 MoO 4 .2H 2 0, 0.2 mg of CuSO 4 .5H 2 0, 0.4 mg of CoCl 2 .6H 2 0, and 1 mg of MnCl 2 .2H 2 0, supplemented with a carbon source as specified.
- Luria broth (L-broth: 10 g/l Bacto trypton (Difco), 5 g/l yeast extract (Difco), 5 g/l NaCl) was used as a complete medium for propagation of P. putida S12 and derivative strains, C. basilensis, M. radiotolerans and E. coli DH5 ⁇ and derivatives.
- L-broth was solidified with 1.5% (w/v) of agar (Difco).
- Ampicillin (Amp) was added to the media to 100 ⁇ g/ml for selection of E. coli transformants carrying pJT′mcs or pJNNmcs(t)-derived plasmids.
- Gentamicin (Gm) was added to 30 ⁇ g/ml in Luria broth and 10 ⁇ g/ml in mineral salts medium for selection of P. putida S12 transformants carrying pJT′mcs or pJNNmcs(t)-derived plasmids.
- P. putida S12 transformants carrying pJT′mcs or pJNNmcs(t)-derived plasmids 50 ⁇ g/ml of kanamycin (Km) was added to the media.
- Antibiotics were purchased from Sigma-Aldrich.
- P. putida, C. basilensis and M. radiotolerans were cultured at 30° C.; E. coli was cultured at 37° C.
- the feed (4 or 8 M of glycerol in 100 mM MgCl 2 , supplemented with 1 mM of Na-salicylate when required) was started and controlled to allow for growth while maintaining glycerol as the limiting substrate in the culture.
- the HMF feed (4M in demineralized water) was fed via a separate feed pump; the feed rate was adjusted depending on the strain employed and the condition studied.
- the dissolved oxygen tension (DO) was continuously monitored and the stirring speed was adjusted to maintain sufficient aeration.
- CDW content of bacterial cultures was determined by measuring optical density at 600 nm (OD 600 ) using a Biowave Cell Density Meter (WPA Ltd) or a ⁇ Quant MQX200 universal microplate spectrophotometer (Biotek), using flat-bottom 96-well microplates (Greiner).
- An OD 600 of 1.0 corresponds to 0.56 g CDW/L (Biowave) or 1.4 g CDW/L ( ⁇ Quant) for P. putida.
- Furan compounds (FDCA, HMF, HMF-alcohol, HMF-acid and FFA) were analyzed by RP-HPLC as described by Koopman et al. (2010a). Sugars, alcohols and organic acids were also analyzed by HPLC (Agilent 1100 system) using a refractive index (RI) detector. The column used was a Bio-Rad Aminex HPX-87H (300 ⁇ 7.8 mm, hydrogen form, 9 ⁇ m particle size, 8% cross linkage, pH range 1-3) with 5 mM H 2 SO 4 as the eluent at a flow rate of 0.6 ml/min
- HMF was purchased either at Sigma, Eurolabs Ltd (Poynton, UK) or Yore Chemipharm Co. Ltd. (Ningbo, China).
- Analytical standards of FDCA and 5-hydroxymethyl-furoic acid (HMF acid) were purchased from Immunosource B.V. (Halle-Zoersel, Belgium), respectively, Matrix Scientific (Columbia S.C., USA). All other chemicals were purchased from Sigma-Aldrich Chemie B.V. (Zwijndrecht, The Netherlands).
- Genomic DNA was isolated from C. basilensis HMF14 and M. radiotolerans JCM 2831 using the DNeasy tissue kit (QIAGEN). Plasmid DNA was isolated with the QIAprep spin miniprep kit (QIAGEN). Agarose-trapped DNA fragments were isolated with the QIAEXII gel extraction kit (QIAGEN).
- PCR reactions were performed with Accuprime Pfx polymerase (Invitrogen) according to the manufacturer's instructions. Oligonucleotide primers (specified in the examples) were synthesized by MWG Biotech AG (Germany). Plasmid DNA was introduced into electrocompetent cells using a Gene Pulser electroporation device (BioRad). Other standard molecular biology techniques were performed according to Sambrook and Russell (2001).
- the hmfT1 gene (formerly designated mfsl (Koopman et al., 2010a); SEQ ID NO: 7) was amplified from genomic DNA of Cupriavidus basilensis HMF14 by PCR using primers hmfT1(f) (SEQ ID NO: 13) and hmfT1(r) (SEQ ID NO: 14).
- the PCR product was introduced as a 1359-bp EcoRI-NheI fragment in pJNNmcs(t) yielding pJNNhmfT1(t).
- the hmfH gene (SEQ ID NO: 11) including its native ribosome binding site (RBS) was amplified by PCR from genomic DNA of C.
- P. putida S12_B38 was cultured in fed-batches as described in the general methodology section. In the batch phase, a cell density of approximately 3 g CDW/1 was achieved after which the glycerol feed and the HMF feed were started. A control fed-batch culture was performed with P. putida S12_2642 (similar to P. putida S12_hmfH (Koopman et al., 2010b)) which does not express HmfT1.
- FIG. 2 shows the concentrations of FDCA and HMF-acid in HMF-fed cultures of P. putida strains S12_2642 and S12_B38.
- the extensive accumulation of HMF-acid is evident for P. putida S12_2642.
- the HMF-acid accumulation was negligible in the P. putida S 12_B38 culture.
- the reduced HMF-acid accumulation furthermore allowed increased HMF feed rates, which resulted in higher FDCA titers in a considerably shorter process time. This was also clearly reflected in the specific FDCA productivity for the tested strains ( FIG. 3 ).
- the gene with locus tag mrad2831_4728 was amplified from genomic DNA of Methylobacterium radiotolerans JCM2831 by PCR using primers Mrad(f) (SEQ ID NO: 17) and Mrad(r) (SEQ ID NO: 18).
- the PCR product was introduced as a 1381-bp EcoRI-NheI fragment in pJNNmcs(t) yielding pJNN_Mrad(t).
- Plasmids pBT′hmfH see Example I
- pJNN_Mrad(t) were successively introduced into P. putida S12, yielding P. putida S 12_B51.
- P. putida _B51 was cultured in shake flasks on mineral salts medium (4 ⁇ buffer strength) supplemented with 1 g/l yeast extract, 80 mM glycerol, 2 mM glucose, 100 ⁇ M Na-salicylate, 50 ⁇ g/ml kanamycin and 10 ⁇ g/ml gentamicin.
- P. putida S12_B38 was used (see Example I). After overnight culturing, the cultures were supplemented with 80 mM glycerol and 100 ⁇ M Na-salicylate. Subsequently, approximately 10 mM HMF was added and FDCA production was assessed.
- FIG. 4 shows that the HMF-acid accumulation during FDCA production was negligible for both strains, confirming that HmfT1 and the Mrad2831_4728 polypeptide exhibited a similar functionality.
- the FDCA production showed a longer lag phase and a somewhat slower rate, which could be attributed to the lower initial biomass density ( FIG. 4A ).
- the specific maximum FDCA productivity was identical for both strains, i.e., 2.36 mmol FDCA/(g CDW, h), indicating that the Mrad2831_4728 and HmfT1 polypeptides were equally effective in minimizing HMF-acid accumulation and maximizing FDCA production.
- the HMF feed was started at a high rate (20 ml/h; 4 M HMF feed solution) in order to saturate the oxidation capacity of P. putida S12_B38 and provoke the accumulation of HMF and HMF-acid ( FIG. 5 ).
- HMF-acid had accumulated to approximately 20 mM
- the HMF feed rate was lowered to 5 ml/h and the furanics concentrations were monitored.
- the HMF-acid concentration increased to approximately 37 mM due to oxidation of residual accumulated HMF, after which it dropped to less than 2 mM within 5 h, at an HMF feed rate of 0.72 mmol/(g CDW.h).
- the gene encoding an aldehyde dehydrogenase (SEQ ID 26; translated amino acid sequence: SEQ ID 19) associated with the HMF-degradation operon in Cupriavidus basilensis HMF14 (Wierckx et al., 2011) was amplified by PCR using primers FN13 (SEQ ID 33) and FN14 (SEQ ID 34).
- the PCR product was introduced as a 1543-bp NotI fragment in Bsp120I-digested (compatible to NotI) pBT′hmfH (see example I) yielding pBT′hmfH-adh.
- the plasmid variant in which the aldehyde dehydrogenase encoding gene was present in the forward (f) orientation (pBT′hmfH-adh(f)) and pJNNhmfT1(t) (see example I) were successively introduced into P. putida S12.
- the resulting strain, P. putida S12_B97, co-expressed HmfH, HmfT1, and the aldehyde dehydrogenase As a control strain for co-expression of the HmfH oxidoreductase and the aldehyde dehydrogenase (i.e., without the HMF-acid transporter HmfT1), P.
- putida S12_B101 was constructed which only contained pBT′hmfH-adh(f).
- P. putida S 12_B38 (see example I) was used as control strain for co-expression of HmfT1 and HmfH without the aldehyde dehydrogenase.
- P. putida strains S12_B38, S12_B97 and S12_B101 were cultured in shake flasks on mineral salts medium (4 ⁇ buffer strength) supplemented with 1 g/l yeast extract, 80 mM glycerol, 2 mM glucose, 50 ⁇ g/ml kanamycin and 10 ⁇ g/ml gentamicin (note: for strain B101 only kanamycin was added).
- Na-salicylate (1 ⁇ M) was added for induction of hmfT1 in the precultures only. After addition of approximately 10 mM HMF, the accumulation of FDCA and HMF-acid was assessed.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL2006359 | 2011-03-08 | ||
NL2006359A NL2006359C2 (en) | 2011-03-08 | 2011-03-08 | Genetically modified cell and process for use of said cell. |
PCT/NL2012/050141 WO2012064195A2 (en) | 2011-03-08 | 2012-03-07 | Genetically modified cell and process for use of said cell |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2012/050141 A-371-Of-International WO2012064195A2 (en) | 2011-03-08 | 2012-03-07 | Genetically modified cell and process for use of said cell |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/059,857 Continuation US9828616B2 (en) | 2011-03-08 | 2016-03-03 | Genetically modified cell and process for use of said cell |
Publications (2)
Publication Number | Publication Date |
---|---|
US20140073019A1 US20140073019A1 (en) | 2014-03-13 |
US9309546B2 true US9309546B2 (en) | 2016-04-12 |
Family
ID=45873204
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/003,386 Expired - Fee Related US9309546B2 (en) | 2011-03-08 | 2012-03-07 | Genetically modified cell and process for use of said cell |
US15/059,857 Active US9828616B2 (en) | 2011-03-08 | 2016-03-03 | Genetically modified cell and process for use of said cell |
US15/687,192 Active US10023890B2 (en) | 2011-03-08 | 2017-08-25 | Genetically modified cell and process for use of said cell |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/059,857 Active US9828616B2 (en) | 2011-03-08 | 2016-03-03 | Genetically modified cell and process for use of said cell |
US15/687,192 Active US10023890B2 (en) | 2011-03-08 | 2017-08-25 | Genetically modified cell and process for use of said cell |
Country Status (19)
Country | Link |
---|---|
US (3) | US9309546B2 (ru) |
EP (1) | EP2683815B1 (ru) |
JP (2) | JP6017463B2 (ru) |
KR (1) | KR101947202B1 (ru) |
CN (1) | CN103502441B (ru) |
AU (1) | AU2012202889B2 (ru) |
BR (1) | BR112013022915B1 (ru) |
CA (1) | CA2829078C (ru) |
DK (1) | DK2683815T3 (ru) |
EA (1) | EA023764B9 (ru) |
ES (1) | ES2543568T3 (ru) |
HU (1) | HUE027066T2 (ru) |
MX (1) | MX336694B (ru) |
MY (1) | MY161455A (ru) |
NL (1) | NL2006359C2 (ru) |
PL (1) | PL2683815T3 (ru) |
PT (1) | PT2683815E (ru) |
SI (1) | SI2683815T1 (ru) |
WO (1) | WO2012064195A2 (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160257978A1 (en) * | 2011-03-08 | 2016-09-08 | Purac Biochem B.V. | Genetically Modified Cell and Process for Use of Said Cell |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150152452A1 (en) * | 2012-07-20 | 2015-06-04 | Novozymes A/S | Enzymatic Oxidation of 5-Hydroxymethylfurfural and Derivatives Thereof |
US9528133B2 (en) | 2012-09-21 | 2016-12-27 | Synthetic Genomics, Inc. | Compositions and methods for producing chemicals and derivatives thereof |
SG10201702263QA (en) | 2012-09-21 | 2017-05-30 | Synthetic Genomics Inc | Compositions and methods for producing chemicals and derivatives thereof |
US10066223B2 (en) | 2012-11-21 | 2018-09-04 | The Regents Of The University Of California | Nucleic acids useful for integrating into and gene expression in hyperthermophilic acidophilic Archaea |
NL2011027C2 (en) * | 2013-06-24 | 2014-12-29 | Univ Delft Tech | Process for the preparation of 2,5-furandicarboxylic acid. |
CN104371955B (zh) * | 2014-10-30 | 2017-02-08 | 江南大学 | 一种合成2,5‑呋喃二甲酸的土生拉乌尔菌及其应用 |
MX2017010459A (es) * | 2015-02-17 | 2018-04-24 | Purac Biochem Bv | Produccion catalizada por deshidrogenasa de acido 2,5-furan-dicarboxilico. |
CN108368490A (zh) * | 2015-09-21 | 2018-08-03 | 普拉克生化公司 | 真菌产生fdca |
EP3561065A4 (en) * | 2016-12-20 | 2020-08-05 | Kaneka Corporation | METHOD FOR PRODUCING POLYHYDROXYALCANIC ACID AND MICROBES |
EP3366681A1 (en) | 2017-02-28 | 2018-08-29 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | Production of 2,5-furandicarboxylic acid |
EP3378931A1 (en) | 2017-03-21 | 2018-09-26 | Purac Biochem B.V. | Fdca-decarboxylating monooxygenase-deficient host cells for producing fdca |
CN109609397A (zh) * | 2017-10-31 | 2019-04-12 | 天津科技大学 | 一种水产养殖用复合微生物菌剂及应用 |
EP3707251A1 (en) | 2017-11-10 | 2020-09-16 | Shell Oil Company | Methods of producing 2,5-furandicarboxylic acid |
EP3505514A1 (en) | 2017-12-29 | 2019-07-03 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | Method for purifying and removing color of 2,5-furandicarboxylic acid (fdca) |
WO2019132663A1 (en) | 2017-12-29 | 2019-07-04 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method for purifying and removing color of fdca |
JP2022523540A (ja) * | 2019-03-01 | 2022-04-25 | ブラスケム エス.エー. | 4-ヒドロキシメチルフルフラールおよびその誘導体のインビボ合成のための方法 |
CN110591995A (zh) * | 2019-09-12 | 2019-12-20 | 华南理工大学 | 一种共表达重组菌及其在合成呋喃羧酸中的应用 |
CN110724654B (zh) * | 2019-11-22 | 2020-09-29 | 南京科技职业学院 | 一株生产5-羟甲基-2呋喃甲酸的铜绿假单胞菌及其应用 |
TWI735113B (zh) * | 2019-12-23 | 2021-08-01 | 國立清華大學 | 2,5-呋喃二甲酸之製備方法 |
NL2024726B1 (en) | 2020-01-22 | 2021-09-09 | Biomosae B V | Enzymatic crop protection and process for preparing biological crop protection composition |
KR20230040359A (ko) | 2020-07-17 | 2023-03-22 | 트르스티스 오브 보스톤 유니버시티 | 바이러스 검출 시스템 및 그 용도 |
US20240115607A1 (en) | 2021-01-26 | 2024-04-11 | Cytocares (Shanghai) Inc. | Chimeric antigen receptor (car) constructs and nk cells expressing car constructs |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011026913A1 (en) | 2009-09-02 | 2011-03-10 | Dsm Ip Assets B.V. | Polypeptides having oxidoreductase activity and their uses |
WO2011026906A2 (en) | 2009-09-02 | 2011-03-10 | Shell Internationale Research Maatschappij B.V. | Novel microorganism and its use in lignocellulose detoxification |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL2006359C2 (en) * | 2011-03-08 | 2012-04-24 | Bird Engineering B V | Genetically modified cell and process for use of said cell. |
-
2011
- 2011-03-08 NL NL2006359A patent/NL2006359C2/en not_active IP Right Cessation
-
2012
- 2012-03-07 PL PL12709978T patent/PL2683815T3/pl unknown
- 2012-03-07 US US14/003,386 patent/US9309546B2/en not_active Expired - Fee Related
- 2012-03-07 BR BR112013022915-2A patent/BR112013022915B1/pt not_active IP Right Cessation
- 2012-03-07 CN CN201280012453.5A patent/CN103502441B/zh not_active Expired - Fee Related
- 2012-03-07 HU HUE12709978A patent/HUE027066T2/en unknown
- 2012-03-07 MY MYPI2013003233A patent/MY161455A/en unknown
- 2012-03-07 JP JP2013557661A patent/JP6017463B2/ja not_active Expired - Fee Related
- 2012-03-07 EP EP12709978.6A patent/EP2683815B1/en active Active
- 2012-03-07 ES ES12709978.6T patent/ES2543568T3/es active Active
- 2012-03-07 SI SI201230263T patent/SI2683815T1/sl unknown
- 2012-03-07 PT PT127099786T patent/PT2683815E/pt unknown
- 2012-03-07 WO PCT/NL2012/050141 patent/WO2012064195A2/en active Application Filing
- 2012-03-07 CA CA2829078A patent/CA2829078C/en not_active Expired - Fee Related
- 2012-03-07 EA EA201300999A patent/EA023764B9/ru not_active IP Right Cessation
- 2012-03-07 AU AU2012202889A patent/AU2012202889B2/en not_active Ceased
- 2012-03-07 MX MX2013010226A patent/MX336694B/es unknown
- 2012-03-07 KR KR1020137026204A patent/KR101947202B1/ko active IP Right Grant
- 2012-03-07 DK DK12709978.6T patent/DK2683815T3/en active
-
2016
- 2016-03-03 US US15/059,857 patent/US9828616B2/en active Active
- 2016-09-28 JP JP2016190165A patent/JP6327724B2/ja not_active Expired - Fee Related
-
2017
- 2017-08-25 US US15/687,192 patent/US10023890B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011026913A1 (en) | 2009-09-02 | 2011-03-10 | Dsm Ip Assets B.V. | Polypeptides having oxidoreductase activity and their uses |
WO2011026906A2 (en) | 2009-09-02 | 2011-03-10 | Shell Internationale Research Maatschappij B.V. | Novel microorganism and its use in lignocellulose detoxification |
US20110086395A1 (en) * | 2009-09-02 | 2011-04-14 | Koopman Frank Wouter | Novel microorganism and its use in lignocellulose detoxification |
Non-Patent Citations (8)
Title |
---|
Database Uniprot [Online], Database Accession No. B1M730, "XP-002660638", (Apr. 2008). |
Database Uniprot [Online], Database Accession No. Q4J779, "XP-002660639", (Aug. 2005). |
International Search Report for PCT/NL2012/050141 Mailed July 10, 2012. |
Koopman, et al., "Efficient whole-cell biotransformation of 5-(hydroxymethyl)furfural into FDCA, 2,5-furandicarboxylic acid", Bioresource Technology (Aug. 2010), 101(16):6291-6296. |
Koopman, et al., "Identification and characterization of the furfural and 5-(hydroxymethyl)furfural degradation pathways of Cupriavidus basilensis HMF14", Proc Natl Acad Sci USA (Mar. 2010), 107(11):4919-4924. |
Koopman, et al., "Identification and characterization of the furfural and 5-(hydroxymethyl)furfural degradation pathways of Cupriavidus basilensis HMF14, supplemental information", Proc Nati Acad Sci USA (Mar. 2010), 107 (11):1-4. |
Ribeiro, et al., "Cooperative effect of cobalt acetylacetonate and silica in the catalytic cyclization and oxidation of fructose to 2, 5-furandicarboxylic acid", Catalysis Communications (2003), 4(2):83-86. |
Written Opinion-PCT/NL2012/050141. * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160257978A1 (en) * | 2011-03-08 | 2016-09-08 | Purac Biochem B.V. | Genetically Modified Cell and Process for Use of Said Cell |
US9828616B2 (en) * | 2011-03-08 | 2017-11-28 | Purac Biochem B.V. | Genetically modified cell and process for use of said cell |
US10023890B2 (en) | 2011-03-08 | 2018-07-17 | Purac Biochem B.V. | Genetically modified cell and process for use of said cell |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10023890B2 (en) | Genetically modified cell and process for use of said cell | |
US9481900B2 (en) | Polypeptides having oxidoreductase activity and their uses | |
EP3259349B1 (en) | Dehydrogenase-catalysed production of fdca |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: PURAC BIOCHEM B.V., NETHERLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WIERCKX, NICK JOHANNES PETRUS;ELINK SCHUURMAN, TOM DANIEL;KUIJPER, SIPKO MAARTEN;AND OTHERS;SIGNING DATES FROM 20131029 TO 20131114;REEL/FRAME:031673/0012 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20240412 |